These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1465181)

  • 1. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
    Kalaria RN; Kroon SN; Grahovac I; Perry G
    Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
    Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
    Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
    Schätz CR; Geula C; Mesulam M
    Neurosci Lett; 1990 Sep; 117(1-2):56-61. PubMed ID: 2290622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
    Wright CI; Geula C; Mesulam MM
    Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
    Coleman AE; Geula C; Price BH; Mesulam MM
    Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
    Geula C; Greenberg BD; Mesulam MM
    Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
    Ciro A; Park J; Burkhard G; Yan N; Geula C
    Curr Alzheimer Res; 2012 Jan; 9(1):138-43. PubMed ID: 21244353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
    Carson KA; Geula C; Mesulam MM
    Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
    Geula C; Mesulam M
    Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
    Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
    J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.
    Darvesh S; Reid GA; Martin E
    Curr Alzheimer Res; 2010 Aug; 7(5):386-400. PubMed ID: 19939227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM; Geula C; Morán MA
    Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.
    Morán MA; Mufson EJ; Gómez-Ramos P
    Acta Neuropathol; 1993; 85(4):362-9. PubMed ID: 8480510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase fibers and the development of senile plaques.
    Tago H; McGeer PL; McGeer EG
    Brain Res; 1987 Mar; 406(1-2):363-9. PubMed ID: 3567634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.
    Gomez-Ramos P; Mufson EJ; Moran MA
    Brain Res; 1992 Jan; 569(2):229-37. PubMed ID: 1540829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease.
    Perry G; Siedlak SL; Richey P; Kawai M; Cras P; Kalaria RN; Galloway PG; Scardina JM; Cordell B; Greenberg BD
    J Neurosci; 1991 Nov; 11(11):3679-83. PubMed ID: 1941102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
    Perry EK; Tomlinson BE; Blessed G; Bergmann K; Gibson PH; Perry RH
    Br Med J; 1978 Nov; 2(6150):1457-9. PubMed ID: 719462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.